Insider trading · Q3 2026 · CIK 1650664

Editas Medicine, Inc. (EDIT) insider trading.

Name: Editas Medicine, Inc. insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Editas Medicine, Inc. reported 5 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $34K.

Transactions: 5
Purchases (P): 0
Sales (S): 5
Net shares, P minus S: -11,892
Insiders: 3
Last filed: 2026-09-04

Insiders

Insider	Relationship	Transactions	Sales
Burkly Linda	Officer · EVP, CHIEF SCIENTIFIC OFFICER	2	2
Parison Amy	Officer · SVP, Chief Financial Officer	2	2
O'Neill Gilmore Neil	Director, Officer · CEO	1	1

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-09-03	O'Neill Gilmore Neil	S (D)	5,124	$3.04	243,189	Form 4
2026-09-03	Burkly Linda	S (D)	709	$3.04	61,660	Form 4
2026-09-03	Parison Amy	S (D)	453	$3.04	13,839	Form 4
2026-08-03	Parison Amy	S (D)	678	$2.58	14,292	Form 4
2026-07-28	Burkly Linda	S (D)	4,928	$2.67	62,369	Form 4

Transaction codes in this quarter

S: 5

Get EDIT insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1650664&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · EDIT company page · Editas Medicine, Inc. on SEC.gov

Questions

Are insiders buying or selling Editas Medicine, Inc. (EDIT)?

In Q3 2026, insiders at Editas Medicine, Inc. reported 5 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $34K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Editas Medicine, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/edit.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.